These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 12039395

  • 21. Aldose reductase inhibitor fidarestat prevents retinal oxidative stress and vascular endothelial growth factor overexpression in streptozotocin-diabetic rats.
    Obrosova IG, Minchenko AG, Vasupuram R, White L, Abatan OI, Kumagai AK, Frank RN, Stevens MJ.
    Diabetes; 2003 Mar; 52(3):864-71. PubMed ID: 12606532
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Properties of novel aldose reductase inhibitors, M16209 and M16287, in comparison with known inhibitors, ONO-2235 and sorbinil.
    Kato K, Nakayama K, Mizota M, Miwa I, Okuda J.
    Chem Pharm Bull (Tokyo); 1991 Jun; 39(6):1540-5. PubMed ID: 1934175
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Effects of aldose reductase inhibitor (ONO-2235) on human erythrocyte sorbitol concentrations in 75 g oral glucose tolerance tests.
    Kamon N, Mabuchi H, Takeda R, Terashima H.
    Horm Metab Res; 1991 May; 23(5):226-9. PubMed ID: 1908433
    [Abstract] [Full Text] [Related]

  • 28. Epalrestat: an aldose reductase inhibitor for the treatment of diabetic neuropathy.
    Ramirez MA, Borja NL.
    Pharmacotherapy; 2008 May; 28(5):646-55. PubMed ID: 18447661
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Effects of a fructose-rich diet and the aldose reductase inhibitor, ONO-2235, on the development of diabetic neuropathy in streptozotocin-treated rats.
    Hotta N, Kakuta H, Fukasawa H, Kimura M, Koh N, Iida M, Terashima H, Morimura T, Sakamoto N.
    Diabetologia; 1985 Mar; 28(3):176-80. PubMed ID: 3922829
    [Abstract] [Full Text] [Related]

  • 31. Effects of an aldose reductase inhibitor on gastroenteropathy in streptozotocin-diabetic rats.
    Oya M, Hosokawa M, Tsukada H, Fukuda K, Nakamura H, Tsukiyama K, Nagashima K, Fujimoto S, Yamada Y, Seino Y.
    Diabetes Res Clin Pract; 2003 Nov; 62(2):69-77. PubMed ID: 14581143
    [Abstract] [Full Text] [Related]

  • 32. Effect of aldose reductase inhibitor ONO 2235 on reduced sympathetic nervous system activity and peripheral nerve disorders in STZ-induced diabetic rats.
    Yoshida T, Nishioka H, Yoshioka K, Nakano K, Kondo M, Terashima H.
    Diabetes; 1987 Jan; 36(1):6-13. PubMed ID: 3025043
    [Abstract] [Full Text] [Related]

  • 33. Effects of fructose ingestion on sorbitol and fructose 3-phosphate contents of erythrocytes from healthy men.
    Kawaguchi M, Fujii T, Kamiya Y, Ito J, Okada M, Sakuma N, Fujinami T.
    Acta Diabetol; 1996 Jul; 33(2):100-2. PubMed ID: 8870809
    [Abstract] [Full Text] [Related]

  • 34. Aldose reductase inhibition counteracts oxidative-nitrosative stress and poly(ADP-ribose) polymerase activation in tissue sites for diabetes complications.
    Obrosova IG, Pacher P, Szabó C, Zsengeller Z, Hirooka H, Stevens MJ, Yorek MA.
    Diabetes; 2005 Jan; 54(1):234-42. PubMed ID: 15616034
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Effect of a new aldose reductase inhibitor, (E)-3-carboxymethyl-5-[(2E)-methyl-3-phenylpropenylidene]rhodanine (ONO-2235) on peripheral nerve disorders in streptozotocin-diabetic rats.
    Kikkawa R, Hatanaka I, Yasuda H, Kobayashi N, Shigeta Y, Terashima H, Morimura T, Tsuboshima M.
    Diabetologia; 1983 Apr; 24(4):290-2. PubMed ID: 6407887
    [Abstract] [Full Text] [Related]

  • 38. Aldose reductase inhibitor fidarestat attenuates leukocyte-endothelial interactions in experimental diabetic rat retina in vivo.
    Hattori T, Matsubara A, Taniguchi K, Ogura Y.
    Curr Eye Res; 2010 Feb; 35(2):146-54. PubMed ID: 20136425
    [Abstract] [Full Text] [Related]

  • 39. An aldose reductase inhibitor but not myo-inositol blocks enhanced polyphosphoinositide turnover in peripheral nerve from diabetic rats.
    Berti-Mattera L, Day N, Peterson RG, Eichberg J.
    Metabolism; 1996 Mar; 45(3):320-7. PubMed ID: 8606638
    [Abstract] [Full Text] [Related]

  • 40. Ranirestat has a stronger inhibitory activity on aldose reductase and suppresses inflammatory reactions in high glucose-exposed endothelial cells.
    Ishibashi Y, Matsui T, Matsumoto T, Kato H, Yamagishi S.
    Diab Vasc Dis Res; 2016 Jul; 13(4):312-5. PubMed ID: 27190083
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.